Description
VIROLOGY CPRR
Base award description: RADIO AND NON-RADIO PHARMACEUTICALS
Modification chain · 11 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2010-09-30+$890,408= $890,408
- Mod 12010-11-09+$7,891= $898,299
- Mod 22011-04-21+$7,681= $905,981
- Mod 32011-07-11-$383,998= $521,983
- Mod 42011-09-06+$19,540= $541,523
- Mod 52011-10-06+$668,184= $1,209,707
- Mod 72012-10-01+$693,748= $1,903,455
- Mod P000082013-10-01+$712,611= $2,616,065
- Mod P000092014-09-10+$0= $2,616,065
- Mod P000102014-10-01+$937,211= $3,553,276
- Mod P000112017-09-30-$326,196= $3,227,080
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2010-09-30 | +$890,408 | $890,408 | RADIO AND NON-RADIO PHARMACEUTICALS |
| Mod 1· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2010-11-09 | +$7,891 | $898,299 | RADIO AND NON-RADIO PHARMACEUTICALS |
| Mod 2· DEFINITIZE CHANGE ORDER | 2011-04-21 | +$7,681 | $905,981 | RADIO AND NON-RADIO PHARMACEUTICALS |
| Mod 3· FUNDING ONLY ACTION | 2011-07-11 | −$383,998 | $521,983 | RADIO AND NON-RADIO PHARMACEUTICALS |
| Mod 4· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2011-09-06 | +$19,540 | $541,523 | RADIO AND NON-RADIO PHARMACEUTICALS IGF::OT::IGF |
| Mod 5· EXERCISE AN OPTION | 2011-10-06 | +$668,184 | $1,209,707 | RADIO AND NON-RADIO PHARMACEUTICALS |
| Mod 7· EXERCISE AN OPTION | 2012-10-01 | +$693,748 | $1,903,455 | RADIO AND NON-RADIO PHARMACEUTICALS |
| Mod P00008· EXERCISE AN OPTION | 2013-10-01 | +$712,611 | $2,616,065 | RADIO AND NON-RADIO PHARMACEUTICALS |
| Mod P00009· ADDITIONAL WORK (NEW AGREEMENT,FAR PART 6 APPLI | 2014-09-10 | +$0 | $2,616,065 | RADIO AND NON-RADIO PHARMACEUTICALS |
| Mod P00010· ADDITIONAL WORK (NEW AGREEMENT,FAR PART 6 APPLI | 2014-10-01 | +$937,211 | $3,553,276 | VIROLOGY CPRR |
| Mod P00011· CLOSE OUT | 2017-09-30 | −$326,196 | $3,227,080 | VIROLOGY CPRR |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CWN9UGL3NCL9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24226N0711 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $100,008 | FY2026 |
| 36C24126P0328 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $999,797 | FY2026 |
| 36C25726N0407 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $1,400,000 | FY2026 |
| 36C25526N0361 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $228,679 | FY2026 |
| 36C24426N0938 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $650,641 | FY2026 |
| 36C24426D0097 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6515 from 241-NETWORK CONTRACT OFFICE 01 (36C241) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24126P0709 | SUNRISE MEDICAL (US) LLC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $22,142 | FY2026 |
| 36C24126P0711 | EDWARDS LIFESCIENCES LLC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $68,000 | FY2026 |
| 36C24126N0917 | PERMOBIL INC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $17,263 | FY2026 |
| 36C24126P0708 | VERICEL CORPORATION | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $76,400 | FY2026 |
| 36C24126P0671 | HOPELIEF SOLUTIONS LLC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $32,528 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA241P2008_3600_-NONE-_-NONE- · retrieved 2026-09-26.